
Pacific Biosciences of California PACB
$ 1.61
3.21%
Annual report 2025
added 02-25-2026
Country |
|
IPO year |
2010 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
300 M |
Market Cap[1] |
$ 483 M |
EBITDA (LTM) |
$ -298 M |
P/E (LTM) |
-1.38 |
P/S (LTM) |
3.03 |
EPS (LTM) |
-1.13 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 116.23 | 0.6 % | $ 35.3 B | NYSE,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 1.67 | - | $ 2.22 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 25.26 | 3.27 % | $ 702 M | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
CareDx, Inc
CDNA
|
$ 21.52 | 1.37 % | $ 1.15 B | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Illumina
ILMN
|
$ 127.89 | 0.01 % | $ 20.3 B | Nasdaq Global Select Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 16.19 | -0.74 % | $ 490 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Charles River Laboratories International
CRL
|
$ 172.96 | 1.88 % | $ 8.57 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Guardant Health
GH
|
$ 90.69 | 2.0 % | $ 11.4 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 84.36 | 0.04 % | $ 5.69 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 416.53 | 1.46 % | $ 12 B | Nasdaq Global Select Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 2.0 | 1.27 % | $ 8.85 M | Nasdaq Global Select Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.72 | 0.91 % | $ 20 B | NYSE | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Senseonics Holdings
SENS
|
$ 7.07 | 0.21 % | $ 295 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Neogen Corporation
NEOG
|
$ 9.6 | 0.58 % | $ 2.08 B | Nasdaq Global Select Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 52.74 | 0.04 % | $ 2.68 B | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.17 | 1.4 % | $ 4.98 M | Nasdaq Capital Market | ||
|
National Research Corporation
NRC
|
$ 17.26 | 0.17 % | $ 386 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 102.05 | -0.12 % | $ 8.42 B | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 265.38 | 0.62 % | $ 22.1 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 470.88 | 0.28 % | $ 178 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 125.51 | 3.7 % | $ 5.87 B | Nasdaq Global Select Market | ||
|
Trinity Biotech plc
TRIB
|
$ 0.65 | 0.03 % | $ 61.9 M | Nasdaq Global Select Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
NeoGenomics
NEO
|
$ 8.43 | 1.69 % | $ 1.08 B | Nasdaq Global Select Market,SPB | ||
|
Twist Bioscience Corporation
TWST
|
$ 60.75 | -0.31 % | $ 3.63 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.79 | 0.1 % | $ 444 M | Nasdaq Global Select Market,SPB | ||
|
Natera
NTRA
|
$ 206.25 | 1.23 % | $ 20.3 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 197.24 | 0.52 % | $ 21.9 B | NYSE,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.